These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9869259)

  • 1. Effects of KRN4884 (a novel K+ channel opener), levcromakalim, nilvadipine and propranolol on endothelin-1-induced heart disorders in anesthetized rats.
    Harada K; Kawahara J; Okada Y; Uzumaki H; Kusaka M; Tokiwa T
    Jpn J Pharmacol; 1998 Nov; 78(3):261-8. PubMed ID: 9869259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with levcromakalim, nilvadipine, and nifedipine.
    Izumi H; Jinno Y; Kaneta S; Tanaka Y; Okada Y; Izawa T; Ogawa N
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):189-97. PubMed ID: 7475042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive properties of KRN4884, a novel long-lasting potassium channel opener.
    Kawahara J; Kashiwabara T; Ogawa N; Okada Y; Izawa T
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):292-4. PubMed ID: 10028939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs.
    Kawahara J; Jinno Y; Endo M; Izumi H; Takeuchi A; Izawa T
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):814-9. PubMed ID: 9234664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the potassium channel openers KRN4884 and levcromakalim on the contraction of rat aorta induced by A23187, compared with nifedipine.
    Kawahara J; Izumi H; Okada Y; Izawa T
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):460-5. PubMed ID: 8897449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo vasodilating effects of KRN4884, Ki1769 and Ki3005, pyridinecarboxamidine derivatives.
    Izumi H; Kawahara J; Takeuchi A; Izawa T; Ogawa N
    Fundam Clin Pharmacol; 1997; 11(6):561-6. PubMed ID: 9444524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of KRN2391, nicorandil and diltiazem on the changes in the electrocardiogram caused by endothelin-1 in anaesthetized rats.
    Harada K; Miwa A; Kaneta S; Izawa T; Fukushima H; Ogawa N
    Br J Pharmacol; 1993 Jul; 109(3):679-84. PubMed ID: 7689399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of the K+ channel opener KRN4884 on peripheral occlusive arterial disease in rats.
    Yoshino T; Ohta H; Jinno Y; Torii Y; Ogawa N; Izawa T; Okada Y
    Gen Pharmacol; 1998 Jul; 31(1):59-62. PubMed ID: 9595280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of the novel potassium channel opener UR-8225.
    Tamargo J; Pérez O; Delpón E; García-Rafanell J; Gómez L; Cavalcanti F
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):295-305. PubMed ID: 7475055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of KRN4884, a novel K+ channel opener, on ionic currents in rabbit femoral arterial myocytes.
    Muraki K; Sasaoka A; Ohya S; Watanabe M; Imaizumi Y
    J Pharmacol Sci; 2003 Nov; 93(3):289-98. PubMed ID: 14646246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of cardiac ATP-sensitive K+ channels by KRN4884, a novel K+ channel opener.
    Shinbo A; Ono K; Iijima T
    J Pharmacol Exp Ther; 1997 Nov; 283(2):770-7. PubMed ID: 9353397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the K+ channel opener KRN4884 on the cardiovascular metabolic syndrome model in rats.
    Okada Y; Yoshino T; Takeuchi A; Endoh M; Ohta H; Jinno Y; Yokoyama T; Izawa T; Kobayshi E
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):287-93. PubMed ID: 10672863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener.
    Lee YM; Yen MH; Peng YY; Sheu JR; Chen YC; Chang MJ; Cheng CY
    Eur J Pharmacol; 2000 May; 397(1):151-60. PubMed ID: 10844109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of levcromakalim and cromakalim on ATP-sensitive K+ channel of pulmonary arterial smooth muscle cells in pulmonary hypertensive rats].
    Xiao XR; Cheng DY; Chen WB
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):97-100. PubMed ID: 12783661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of JTV-506, a novel vasodilator, on experimental angina model in rats.
    Hirata Y; Miyai H; Mabuchi Y; Aisaka K
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):322-6. PubMed ID: 9475276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti- and proconvulsive actions of levcromakalim, an opener of ATP-sensitive K+ channel, in the model of hippocampus-generating partial seizures in rats.
    Katsumori H; Ito Y; Higashida H; Hashii M; Minabe Y
    Eur J Pharmacol; 1996 Sep; 311(1):37-44. PubMed ID: 8884234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship of a novel K+ channel opener, KRN4884, and related compounds in porcine coronary artery.
    Izumi H; Tanaka Y; Okada Y; Ogawa N; Izawa T
    Gen Pharmacol; 1996 Sep; 27(6):985-9. PubMed ID: 8909979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB; Welch SP
    Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of potassium channel opener KRN4884 on human conduit arteries used as coronary bypass grafts.
    Ren Z; Floten S; Furnary A; Liu M; Gately H; Swanson J; Ahmad A; Yim AP; He GW
    Br J Clin Pharmacol; 2000 Aug; 50(2):154-60. PubMed ID: 10930967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the airways relaxant and hypotensive potencies of the potassium channel activators BRL 55834 and levcromakalim (BRL 38227) in vivo in guinea-pigs and rats.
    Bowring NE; Arch JR; Buckle DR; Taylor JF
    Br J Pharmacol; 1993 Aug; 109(4):1133-9. PubMed ID: 8401925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.